WANSFORD — All Prescriptions & Medications — Page 3
Practice Code: K83017 | PETERBOROUGH, PE8 6PL
Showing results 101-150 of 648
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Duloxetine hydrochloride | 548 | 16.5K | £1.6K | -13.8% ▼ |
| Sumatriptan succinate | 523 | 4,240 | £6.0K | +47.7% ▲ |
| Pravastatin sodium | 515 | 12.1K | £549 | +58.6% ▲ |
| Oxycodone hydrochloride | 514 | 56.1K | £9.0K | +100.8% ▲ |
| Ibuprofen | 500 | 48.8K | £1.8K | -1.7% vs avg |
| Pantoprazole | 497 | 18.4K | £847 | +80.8% ▲ |
| Desogestrel | 491 | 54.4K | £1.9K | +23.9% ▲ |
| Semaglutide | 488 | 14.7K | £37.7K | +102.7% ▲ |
| Beclometasone dipropionate | 488 | 488 | £1.4K | +126.9% ▲ |
| Bimatoprost | 487 | 4,014 | £3.7K | +227.6% ▲ |
| Cefalexin | 475 | 11.0K | £755 | +308.4% ▲ |
| Methotrexate | 473 | 9,562 | £6.1K | +45.3% ▲ |
| Buprenorphine | 451 | 1,635 | £7.3K | +23.1% ▲ |
| Diazepam | 447 | 14.3K | £359 | -10.3% ▼ |
| Ranolazine | 445 | 18.9K | £3.4K | +161.9% ▲ |
| Tiotropium bromide | 445 | 5,752 | £10.4K | +46.4% ▲ |
| Mesalazine (Systemic) | 438 | 42.0K | £20.2K | +82.8% ▲ |
| Insulin aspart | 435 | 2,358 | £17.0K | +14.2% ▲ |
| Fluticasone propionate (Inhalation) | 418 | 430 | £10.8K | +8.0% ▲ |
| Combined ethinylestradiol 30mcg | 415 | 38.1K | £2.5K | +49.4% ▲ |
| Bisacodyl | 409 | 9,417 | £539 | +212.0% ▲ |
| 399 | 728 | £617 | +81.1% ▲ | |
| Thiamine hydrochloride | 386 | 14.4K | £386 | -26.8% ▼ |
| Betahistine hydrochloride | 385 | 21.4K | £713 | +61.3% ▲ |
| 384 | 388 | £16.7K | +23.6% ▲ | |
| Betamethasone valerate | 382 | 30.5K | £1.9K | -0.8% vs avg |
| Timolol | 380 | 8,680 | £2.4K | +329.6% ▲ |
| Tadalafil | 376 | 5,572 | £1.1K | +121.1% ▲ |
| Lactulose | 372 | 184.5K | £1.7K | +13.0% ▲ |
| 368 | 41.9K | £1.8K | +180.9% ▲ | |
| Co-beneldopa (Benserazide/levodopa) | 362 | 52.4K | £3.3K | +139.5% ▲ |
| Docusate sodium | 358 | 15.0K | £1.1K | -3.4% ▼ |
| Estradiol with progestogen | 358 | 12.7K | £12.2K | +5.0% ▲ |
| Hyoscine butylbromide | 353 | 25.3K | £1.7K | +51.5% ▲ |
| Alfacalcidol | 349 | 11.9K | £2.6K | +182.2% ▲ |
| Alogliptin | 347 | 6,713 | £6.0K | +36.8% ▲ |
| Lidocaine hydrochloride | 344 | 2,004 | £2.6K | +99.4% ▲ |
| Melatonin | 337 | 23.2K | £5.5K | +1.3% vs avg |
| Mebeverine hydrochloride | 335 | 23.1K | £847 | +7.9% ▲ |
| Escitalopram | 331 | 8,862 | £618 | +16.3% ▲ |
| Flecainide acetate | 330 | 14.7K | £498 | +322.7% ▲ |
| Nifedipine | 328 | 11.1K | £3.0K | +75.0% ▲ |
| Lorazepam | 324 | 6,939 | £862 | +127.3% ▲ |
| Dorzolamide and timolol | 315 | 7,440 | £4.7K | +120.1% ▲ |
| Calcipotriol | 312 | 23.5K | £12.7K | +83.3% ▲ |
| Quinine sulfate | 310 | 6,027 | £908 | +7.1% ▲ |
| Lymecycline | 297 | 8,778 | £1.0K | +146.9% ▲ |
| Insulin glargine | 295 | 1,301 | £12.3K | +3.9% ▲ |
| Paroxetine hydrochloride | 294 | 8,124 | £416 | +57.6% ▲ |
| Clobetasone butyrate | 291 | 14.4K | £1.8K | +42.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.